Literature DB >> 26838265

Functional neuroimaging in obesity and the potential for development of novel treatments.

Haiko Schlögl1, Annette Horstmann2, Arno Villringer3, Michael Stumvoll4.   

Abstract

Recently, exciting progress has been made in understanding the role of the CNS in controlling eating behaviour and in the development of overeating. Regions and networks of the human brain involved in eating behaviour and appetite control have been identified with neuroimaging techniques such as functional MRI, PET, electroencephalography, and magnetoencephalography. Hormones that regulate our drive to eat (eg, leptin, insulin, and glucagon-like peptide-1) can affect brain function. Defects in central hunger signalling are present in many pathologies. On the basis of an understanding of brain mechanisms that lead to overeating, powerful neuroimaging protocols could be a future clinical approach to allow individually tailored treatment options for patients with obesity. The aim of our Review is to provide an overview of neuroimaging approaches for obesity (ie, neuroimaging study design, questions which can be answered by neuroimaging, and limitations of neuroimaging techniques), examine current models of central nervous processes regulating eating behaviour, summarise and review important neuroimaging studies investigating therapeutic approaches to treat obesity or to control eating behaviour, and to provide a perspective on how neuroimaging might lead to new therapeutic approaches to obesity.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26838265     DOI: 10.1016/S2213-8587(15)00475-1

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  8 in total

1.  Sleeve Gastrectomy Rescuing the Altered Functional Connectivity of Lateral but Not Medial Hypothalamus in Subjects with Obesity.

Authors:  Panlong Li; Han Shan; Binbin Nie; Hua Liu; Guanglong Dong; Yulin Guo; Jin Du; Hongkai Gao; Lin Ma; Demin Li; Baoci Shan
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

2.  Body mass is positively associated with neural response to sweet taste, but not alcohol, among drinkers.

Authors:  Casey K Gardiner; Sophie L YorkWilliams; Angela D Bryan; Kent E Hutchison
Journal:  Behav Brain Res       Date:  2017-05-23       Impact factor: 3.332

Review 3.  Obesity and Brain Positron Emission Tomography.

Authors:  Kyoungjune Pak; Seong-Jang Kim; In Joo Kim
Journal:  Nucl Med Mol Imaging       Date:  2017-05-19

Review 4.  Brain Imaging of Taste Perception in Obesity: a Review.

Authors:  Christopher Kure Liu; Paule Valery Joseph; Dana E Feldman; Danielle S Kroll; Jamie A Burns; Peter Manza; Nora D Volkow; Gene-Jack Wang
Journal:  Curr Nutr Rep       Date:  2019-06

Review 5.  The influence of the subcortex and brain stem on overeating: How advances in functional neuroimaging can be applied to expand neurobiological models to beyond the cortex.

Authors:  Po-Han Kung; Carles Soriano-Mas; Trevor Steward
Journal:  Rev Endocr Metab Disord       Date:  2022-04-05       Impact factor: 9.306

6.  Non-invasive Prefrontal/Frontal Brain Stimulation Is Not Effective in Modulating Food Reappraisal Abilities or Calorie Consumption in Obese Females.

Authors:  Felicitas Grundeis; Cristin Brand; Saurabh Kumar; Michael Rullmann; Jan Mehnert; Burkhard Pleger
Journal:  Front Neurosci       Date:  2017-06-20       Impact factor: 4.677

7.  Adiposity Related Brain Plasticity Induced by Bariatric Surgery.

Authors:  Michael Rullmann; Sven Preusser; Sindy Poppitz; Stefanie Heba; Konstantinos Gousias; Jana Hoyer; Tatjana Schütz; Arne Dietrich; Karsten Müller; Mohammed K Hankir; Burkhard Pleger
Journal:  Front Hum Neurosci       Date:  2019-08-27       Impact factor: 3.169

8.  Oxytocin reduces the functional connectivity between brain regions involved in eating behavior in men with overweight and obesity.

Authors:  Liya Kerem; Nouchine Hadjikhani; Laura Holsen; Elizabeth A Lawson; Franziska Plessow
Journal:  Int J Obes (Lond)       Date:  2019-11-18       Impact factor: 5.095

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.